p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.
about
Genetic modifiers of cancer risk in Lynch syndrome: a reviewMDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European CaucasiansMSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.Molecular basis for subdividing hereditary colon cancer?Haplotype structure and selection of the MDM2 oncogene in humans.TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.Gene-gene, gene-environment & multiple interactions in colorectal cancer.Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients.Genetic variation and its role in malignancyPolymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.p53 polymorphisms: cancer implications.Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study.Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis.Chronic inflammation, colorectal cancer and gene polymorphisms.Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibilityMDM2 SNP309 accelerates colorectal tumour formation in women.Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.The codon 47 polymorphism in p53 is functionally significant.TP53 single nucleotide polymorphism rs1042522 in salivary gland neoplasms.Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population.
P2860
Q27004353-0679F9E3-9D42-4616-9AF8-0ACFA25E3DBBQ33330490-B76AF97A-96EB-46EF-9743-794B1DD6C8AAQ33933576-92D2A3C3-EF8F-4518-B81D-9648D4D21889Q34153776-D2D06A4B-FF45-4CE9-A647-4A5419B23E3CQ35152037-8D592A39-7F33-4764-80D0-8CACDD345039Q35240086-F7814A27-51AC-434E-8B8B-E0D27E6BA2B5Q35597947-7A2DC8E6-095C-40D0-A98F-0F0D9DFBBF0AQ35721519-8590E89A-1B22-4D5A-9911-2527ABA1FDEEQ36210453-EEED5F0E-D978-4F9A-BBA1-21178122D25AQ36396727-8DDDCC6E-44A5-442F-8EAC-887239DBF5CCQ36475800-2E05450E-8E49-4967-89BE-2EED550338ADQ36587635-A8A0DA2E-8C90-4F5D-B7F0-669C7D139587Q36735686-2852E68A-8886-4B1E-B2CE-0AF6439DDDA4Q37293815-E36DDF5E-0CAF-4992-A740-5B7252DB0195Q37376012-39C6E534-8EDF-43F8-9A1D-42E7BE245BB1Q37485098-10648948-26ED-49C4-AD04-386578A299D7Q37566958-DCFD1594-D04F-4B6A-9719-D56E57536998Q37702059-31CA5685-D253-4B3E-A1FF-7DC8EF344858Q38784192-066E9560-D10F-4C74-B3A5-62BADE357F2DQ41203019-5165BB4A-2BAE-4FD0-9644-A088A2B79DFAQ42086146-724258AE-583B-4A3C-818A-95833D1A892BQ42239266-359E91C3-9772-459F-8C3F-CF5D430FBDCCQ43146294-C6F70272-5033-4F4C-9927-425E1CC38EBCQ44000617-80F9C153-1FCE-443F-B78A-75EC7600BAACQ46455258-E7C56B33-8FBE-48DE-9318-8078816CB0ACQ54240085-B3F979C6-3DE7-4AE7-880A-47FD36539DCBQ54345300-2E40B739-12E2-4D67-A79D-8DCBFD0D108D
P2860
p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
p53 polymorphism and age of on ...... cer in a Caucasian population.
@en
p53 polymorphism and age of on ...... cer in a Caucasian population.
@nl
type
label
p53 polymorphism and age of on ...... cer in a Caucasian population.
@en
p53 polymorphism and age of on ...... cer in a Caucasian population.
@nl
prefLabel
p53 polymorphism and age of on ...... cer in a Caucasian population.
@en
p53 polymorphism and age of on ...... cer in a Caucasian population.
@nl
P2093
P1476
p53 polymorphism and age of on ...... cer in a Caucasian population.
@en
P2093
J Shawn Jones
Marsha L Frazier
Patrick M Lynch
Xiangjun Gu
Xuedong Chi
P304
P356
10.1158/1078-0432.CCR-03-0590
P407
P577
2004-09-01T00:00:00Z